Investigation of GLP1-Receptor Agonists in Men With Prostate Cancer Taking Androgen Deprivation Therapy

NCT06908694 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Semaglutide Pen Injector

Sponsor

Hamilton Health Sciences Corporation

Collaborators

[object Object]